Information
Editors
Microscopic Colitis
Essentials
- Microscopic colitis is discovered in about 10% of patients who have undergone colonoscopy for chronic diarrhoea.
- Diagnosis is based on histological biopsy samples collected during a colonoscopy.
- The most common subtypes: collagenous colitis and lymphocytic colitis
- Aetiology and pathogenesis are unknown.
- A benign disease, varied clinical course, medication only if necessary
Epidemiology
- Incidence about 10 new cases/100 000 person years
- More common in women than in men
- Occurrence is more common after the age of 50 years and increases with age, but the disease may also occur in children.
Symptoms
- Chronic non-bloody diarrhoea
- Abdominal bloating, flatulence, bowel urgency, incontinence
- Weight loss, lethargy
Diagnosis
- Colonoscopy
- The endoscopic view often has a normal appearance.
- Tissue biopsies must always be taken if diarrhoea is the principal symptom.
- Histological analysis will reveal, among other things, inflammatory changes in the lamina propria and degeneration of the epithelium.
- Collagenous colitis: thickened subepithelial collagen layer
- Lymphocytic colitis: increase in the number of intraepithelial cells, mainly lymphocytes
- Inflammatory changes throughout the entire large bowel, most markedly at its start and midsection, sometimes also in the ileum
- Laboratory investigations are those used in the basic examination of any patient with diarrhoea; see also article Prolonged diarrhoea in the adult Prolonged Diarrhoea in Adults.
- Basic blood count with platelet count, ESR, CRP, sodium, potassium, creatinine
- Thyroid-stimulating hormone (TSH), transglutaminase antibodies
- Faecal calprotectin normal or elevated
Associated conditions and medicines
- The incidence of autoimmune diseases is high among patients, particularly coeliac disease must be excluded
- Rheumatic conditions, collagenosis, different pain syndromes, fibromyalgia
- Possible link with medicines: aspirin, other NSAIDs, proton pump inhibitors (PPI) or H2-receptor blockers; SSRIs
Treatment
Other medicines, if symptomatic medication and treatment are not sufficient
- Cholestyramine is effective in some patients even in the absence of co-existing bile acid malabsorption: (½-1 sachet 1-3 times daily)
- The patient may try stopping the medicine during an asymptomatic phase
- Note! Cholestyramine affects the absorption of other medicines
- Glucocorticoids (bear the adverse effects in mind)
- Budesonide SIR
- Administered as a course with gradually decreasing doses
- E.g. 9 mg for 1-2 months, 6 mg for 1-2 months, 3 mg for 1-2 months
- Best proven efficacy, but the symptoms often recur when the medication is discontinued
- Budesonide MMS
- Budesonide is released in the colon.
- Used in ulcerative colitis
- Evidence is so far lacking for the use in microscopic colitis.
- Courses of prednisolone if the above medication proves ineffective
- 5-ASA medications as in ulcerative colitis
- Sometimes azathioprine, methotrexate, TNF-alpha inhibitors
- In the presence of very severe symptoms, continual need for glucocorticoids; in specialist care!
- National legislation as regards the reimbursement of medicines applies.
Prognosis and follow-up
- The prognosis is good.
- Spontaneous remissions and several years with no symptoms are possible
- Not known to increase the risk of, for example, bowel cancer.
- No need for endoscopic follow-up
- Evaluation and management by a specialist is indicated if the symptoms are troublesome and the patient needs repeated courses of budesonide.